Novel DES Aims at Full Thromboresistance: Another Promising Player on the Field?

Cardiovasc Revasc Med. 2021 Nov:32:25-26. doi: 10.1016/j.carrev.2021.07.029. Epub 2021 Aug 11.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Drug-Eluting Stents*
  • Humans